Potential effects of reclassifying CKD as a coronary heart disease risk equivalent in the us population

American Journal of Kidney Diseases

Volumn 63, Issue 5, 2014, Pages 753-760

  Foster, Meredith C ^a   Rawlings, Andreea M ^a   Marrett, Elizabeth ^b   Neff, David ^b   Grams, Morgan E ^a,c   Kasiske, Bertram L ^d   Willis, Kerry ^e   Inker, Lesley A ^f   Coresh, Josef ^a,g,h   Selvin, Elizabeth ^a,g  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b MERCK RESEARCH LABORATORIES   (United States)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d HENNEPIN COUNTY MEDICAL CENTER   (United States)

^e NATIONAL KIDNEY FOUNDATION   (United States)

^f TUFTS MEDICAL CENTER   (United States)

^g JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^h JOHNS HOPKINS HOSPITAL   (United States)

Author keywords

cholesterol treatment guidelines; Chronic kidney disease; coronary heart disease (CHD) risk equivalents; guideline implementation; Index Words; low density lipoprotein (LDL) cholesterol; National Health and Nutrition Examination Survey (NHANES); public health

Indexed keywords

ALBUMIN; CHOLESTEROL; CREATININE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; ALBUMIN BLOOD LEVEL; ARTICLE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CHRONIC KIDNEY DISEASE; CREATININE BLOOD LEVEL; CROSS-SECTIONAL STUDY; DIABETES MELLITUS; DYSLIPIDEMIA; FEMALE; GLOMERULUS FILTRATION RATE; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; PRACTICE GUIDELINE; RISK ASSESSMENT; SMOKING; TRIACYLGLYCEROL BLOOD LEVEL;

CHOLESTEROL TREATMENT GUIDELINES; CHRONIC KIDNEY DISEASE; CORONARY HEART DISEASE (CHD) RISK EQUIVALENTS; GUIDELINE IMPLEMENTATION; LOW-DENSITY LIPOPROTEIN (LDL) CHOLESTEROL; NATIONAL HEALTH AND NUTRITION EXAMINATION SURVEY (NHANES); PUBLIC HEALTH;

ADULT; AGED; CHOLESTEROL, LDL; CORONARY DISEASE; CROSS-SECTIONAL STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; NUTRITION SURVEYS; PUBLIC HEALTH; RENAL INSUFFICIENCY, CHRONIC; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; UNITED STATES; YOUNG ADULT;

EID: 84898610079     PISSN: 02726386     EISSN: 15236838     Source Type: Journal    
DOI: 10.1053/j.ajkd.2013.11.014     Document Type: Article

References (30)

1. Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report Circulation 106 25 2002 3143 3421
2. S.M. Grundy, J.I. Cleeman, and C.N. Merz et al. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines Circulation 110 2 2004 227 239
3. K. Matsushita, M. van der Velde, and B.C. Astor et al. Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis Lancet 375 9731 2010 2073 2081
4. M. van der Velde, K. Matsushita, and J. Coresh et al. Lower estimated glomerular filtration rate and higher albuminuria are associated with all-cause and cardiovascular mortality. A collaborative meta-analysis of high-risk population cohorts Kidney Int 79 12 2011 1341 1352
5. M. Tonelli, P. Muntner, and A. Lloyd et al. Risk of coronary events in people with chronic kidney disease compared with those with diabetes: a population-level cohort study Lancet 380 9844 2012 807 814
6. National Kidney Foundation K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification Am J Kidney Dis 39 suppl 2 2002 S1 S266
7. M.J. Sarnak, A.S. Levey, and A.C. Schoolwerth et al. Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention Circulation 108 17 2003 2154 2169
8. National Kidney Foundation KDOQI clinical practice guidelines for managing dyslipidemias in chronic kidney disease Am J Kidney Dis 41 suppl 3 2003 S1 S92
9. A.L. Catapano, Z. Reiner, and G. De Backer et al. ESC/EAS guidelines for the management of dyslipidaemias: the Task Force for the Management of Dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS) Atherosclerosis 217 suppl 1 2011 S1 S44
10. Centers for Disease Control and Prevention (CDC). National Center for Health Statistics (NCHS). NHANES-Questionnaires, datasets, and related documentation. http://www.cdc.gov/nchs/nhanes/nhanes-questionnaires.htm. Accessed May 29, 2013.
11. Centers for Disease Control and Prevention (CDC). National Center for Health Statistics (NCHS). NHANES-NCHS Research Ethics Review Board approval. http://www.cdc.gov/nchs/nhanes/irba98.htm. Accessed May 29, 2013.
12. Centers for Disease Control and Prevention (CDC). National Center for Health Statistics (NCHS). NHANES-NHANES 2007-2008-general release file documentation. http://www.cdc.gov/nchs/nhanes/nhanes2007-2008/generaldoc-e.htm. Accessed May 29, 2013.
13. Centers for Disease Control and Prevention (CDC). National Center for Health Statistics (NCHS). NHANES-NHANES 2009-2010-general release file documentation. http://www.cdc.gov/nchs/nhanes/nhanes2009-2010/generaldoc-f.htm. Accessed May 29, 2013.
14. Centers for Disease Control and Prevention (CDC). National Center for Health Statistics (NCHS). 2007-2008 National Health and Nutrition Examination Survey (NHANES) survey operations manuals, brochures, consent documents. http://www.cdc.gov/nchs/nhanes/nhanes2007-2008/nhanes07-08.htm. Accessed May 29, 2013.
15. Centers for Disease Control and Prevention (CDC). National Center for Health Statistics (NCHS). 2009-2010 National Health and Nutrition Examination Survey (NHANES) survey operations manuals, brochures, consent documents. http://wwwn.cdc.gov/nchs/nhanes/search/nhanes09-10.aspx. Accessed May 29, 2013.
16. A.S. Levey, L.A. Stevens, and C.H. Schmid et al. A new equation to estimate glomerular filtration rate Ann Intern Med 150 9 2009 604 612
17. Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int Suppl. 3(1):1-150.
18. Centers for Disease Control and Prevention (CDC). National Center for Health Statistics (NCHS). Continuous NHANES web tutorial: specifying weighting parameters: weighting in NHANES. http://www.cdc.gov/nchs/tutorials/NHANES/SurveyDesign/Weighting/OverviewKey.htm. Accessed May 29, 2013.
19. C. Baigent, M.J. Landray, and C. Reith et al. The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial Lancet 377 9784 2011 2181 2192
20. A. Upadhyay, A. Earley, J.L. Lamont, S. Haynes, C. Wanner, and E.M. Balk Lipid-lowering therapy in persons with chronic kidney disease: a systematic review and meta-analysis Ann Intern Med 157 4 2012 251 262
21. S.C. Palmer, J.C. Craig, S.D. Navaneethan, M. Tonelli, F. Pellegrini, and G.F. Strippoli Benefits and harms of statin therapy for persons with chronic kidney disease: a systematic review and meta-analysis Ann Intern Med 157 4 2012 263 275
22. A.D. Hyre, C.S. Fox, B.C. Astor, A.J. Cohen, and P. Muntner The impact of reclassifying moderate CKD as a coronary heart disease risk equivalent on the number of US adults recommended lipid-lowering treatment Am J Kidney Dis 49 1 2007 37 45
23. M.D. Carroll, B.K. Kit, D.A. Lacher, S.T. Shero, and M.E. Mussolino Trends in lipids and lipoproteins in US adults, 1988-2010 JAMA 308 15 2012 1545 1554
24. M.C. Foster, A.M. Rawlings, and E. Marrett et al. Cardiovascular risk factor burden, treatment, and control among adults with chronic kidney disease in the United States Am Heart J 166 1 2013 150 156
25. M. Tonelli Should CKD be a coronary heart disease risk equivalent? Am J Kidney Dis 49 1 2007 8 11
26. C.M. Clase, P. Gao, and S.W. Tobe et al. Estimated glomerular filtration rate and albuminuria as predictors of outcomes in patients with high cardiovascular risk: a cohort study Ann Intern Med 154 5 2011 310 318
27. P.E. Drawz, S. Baraniuk, and B.R. Davis et al. Cardiovascular risk assessment: addition of CKD and race to the Framingham equation Am Heart J 164 6 2012 925 931. e922
28. C. Wanner, V. Krane, and W. Marz et al. Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis N Engl J Med 353 3 2005 238 248
29. B.C. Fellstrom, A.G. Jardine, and R.E. Schmieder et al. Rosuvastatin and cardiovascular events in patients undergoing hemodialysis N Engl J Med 360 14 2009 1395 1407
30. B.C. Astor, S.I. Hallan, E.R. Miller III, E. Yeung, and J. Coresh Glomerular filtration rate, albuminuria, and risk of cardiovascular and all-cause mortality in the US population Am J Epidemiol 167 10 2008 1226 1234